Boston Scientific Corporation (BSX)

NYSE: BSX · Real-Time Price · USD

97.28

+0.49 (0.51%)

At close: Oct 9, 2025, 4:00 PM EDT

97.68

+0.40 (0.41%)

After-hours: Oct 9, 2025, 7:54 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
MedSurg Revenue	6.39B	5.99B	Log In	Log In	Log In	Upgrade
Cardiovascular Revenue	12.10B	10.76B	Log In	Log In	Log In	Upgrade
Other Revenue	-	-	Log In	Log In	Log In	Upgrade
Revenue (Other)	-	-1.00M	Log In	Log In	Log In	Upgrade
Revenue (Total)	18.49B	16.75B	Log In	Log In	Log In	Upgrade

EBT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
MedSurg Income Before Taxes	-	-	Log In	Log In	Log In	Upgrade
Cardiovascular Income Before Taxes	-	-	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
MedSurg Organic Revenue Growth	-	7.50%	Log In	Log In	Log In	Upgrade
Rhythm & Neuro Organic Revenue Growth	-	-	Log In	Log In	Log In	Upgrade
Cardiovascular Organic Revenue Growth	-	21.90%	Log In	Log In	Log In	Upgrade

Updated Jul 23, 2025. Data Source: Fiscal.ai.